Barclays Maintains Equal-Weight on Privia Health Gr, Lowers Price Target to $19
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Andrew Mok maintains an Equal-Weight rating on Privia Health Group (NASDAQ:PRVA) but lowers the price target from $22 to $19.
May 20, 2024 | 2:10 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Barclays analyst Andrew Mok maintains an Equal-Weight rating on Privia Health Group but lowers the price target from $22 to $19.
The lowered price target from $22 to $19 by Barclays suggests a less optimistic outlook for Privia Health Group, which could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100